Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 180 participants.
Also called NCT07238972
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT07238972
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07238972. Randomized; single masking; primary purpose treatment. Start 2025-12 (anticipated); primary completion 2030-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery
- Condition
- Anemia
- Condition
- Iron Deficiencies
- Condition
- Iron Deficiency Anemia
- Condition
- Cardiac Surgery
- Condition
- Heart Valve Diseases
- Intervention (Drug)
- Ferric derisomaltose
- Intervention (Drug)
- Placebo (0.9% saline)
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct07238972- Content hash
699dc81a7314b145705642b68652d4f1f86b7df994b66df87a95ab961c02ba14